October 21, 2021

Cedilla Therapeutics

Cedilla Therapeutics Unveils Lead Programs for the Conditional Inhibition of TEAD and CDK2, Two High Value and Historically Undruggable Cancer Drivers

October 20, 2021

Voyager Therapeutics

Voyager Therapeutics Presents Positive Preclinical Data Supporting CNS-Directed GBA1 Gene Therapy At Virtual Congress Of The European Society Of Gene And Cell Therapy

October 15, 2021

Goldfinch Bio

Goldfinch Bio Announces Upcoming Presentations at American Society of Human Genetics (ASHG) 2021 Meeting and American Society of Nephrology’s (ASN) Kidney Week 2021go

October 13, 2021

Rheos Medicines

Rheos Medicines to Present Data at ACR 2021 for MALT1 Inhibitors in Autoimmune and Inflammatory Disease and Announces RHX-317 as First Development Candidate

October 13, 2021

Ambys Medicines

Ambys Medicines announces John Choi is joining as VP of Regulatory Affairs as it initiates IND activities for its lead allogeneic liver cell transplantation program

Load More

Sign up for weekly portfolio news.